Stay updated on EXN407 Safety & Tolerability Clinical Trial

Sign up to get notified when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EXN407 Safety & Tolerability Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    0.9%
    Check dated 2025-07-11T07:23:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T04:07:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-19T19:43:58.000Z thumbnail image
  5. Check
    30 days ago
    No Change Detected
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:18:39.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:01:15.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated to include new results and detailed descriptions of the study involving EXN407, including specific objectives and methodologies for evaluating ocular safety and pharmacokinetics in subjects with Diabetic Macular Oedema (DMO). Notably, the results reporting dates have also been added.
    Difference
    22%
    Check dated 2025-05-14T23:32:42.000Z thumbnail image

Stay in the know with updates to EXN407 Safety & Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.